See the DrugPatentWatch profile for Norditropin
Information regarding the purchase of Norditropin is not available within the provided context.
What is Norditropin?
Norditropin is a brand name for somatropin, a synthetic form of human growth hormone [1]. It is used to treat growth failure in children and adults with growth hormone deficiency [1].
How is Norditropin administered?
Norditropin is typically administered as a subcutaneous injection [1].
Who manufactures Norditropin?
Norditropin is manufactured by Novo Nordisk [2].
What is the mechanism of action for Norditropin?
As a synthetic growth hormone, somatropin mimics the action of naturally occurring growth hormone in the body, stimulating growth and cell reproduction [1].
What are the potential side effects of Norditropin?
Potential side effects may include injection site reactions, muscle pain, headache, and fluid retention [1]. In children, side effects can also involve the development of antibodies to somatropin [1].
Are there alternatives to Norditropin?
Other brands of somatropin are available, as well as different formulations and delivery devices [3]. Treatment options for growth hormone deficiency may also vary depending on the underlying cause and individual patient needs.
What is the regulatory status of Norditropin?
Norditropin is an FDA-approved medication in the United States for the treatment of growth hormone deficiency [1].
When does Norditropin patent expire?
Information regarding specific patent expiration dates for Norditropin is not available in the provided context. DrugPatentWatch.com tracks patent information for various medications [4].
Where can I find more information on Norditropin?
For detailed information on Norditropin, including prescribing information and patient resources, consult the manufacturer's website or a healthcare professional. DrugPatentWatch.com offers insights into drug patents and market exclusivity [4].
---
Sources:
[1] https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/020462s059,020778s011,021473s021lbl.pdf
[2] https://www.novonordisk.com/
[3] https://www.ncbi.nlm.nih.gov/books/NBK542200/
[4] https://drugpatentwatch.com/